Look out for more information on market dynamics scenario, demand & supply forces, product offerings, financial information, and SWOT analysis. All at affordable Plans
Market Segmentation
The Intravenous Fluid Bags Market is segmented by geography (North America, Europe, APAC, and South America). 36% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for intravenous fluid bags market in North America. Market growth in this region will be faster than the growth of the market in South America. The rising prevalence of chronic diseases will facilitate the intravenous fluid bags market growth in North America over the forecast period.
Intravenous Fluid Bags Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2019 |
Forecast period |
2020-2024 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.67% |
Market growth 2020-2024 |
$ 667.51 million |
Market structure |
Fragmented |
YoY growth (%) |
5.24 |
Regional analysis |
North America, Europe, APAC, and South America |
Performing market contribution |
North America at 36% |
Key consumer countries |
US, Germany, Canada, and China |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
Amcor Ltd., B. Braun Melsungen AG, Baxter International Inc., Fresenius Kabi AG, ICU Medical Inc., JW Lifescience Corp., Merit Medical Systems Inc., PolyCine GmbH, Sippex - A MEDIPPEX Co., and Smiths Medical Group Ltd. |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period, |
Customization preview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Company Profiles
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
- Amcor Ltd.
- B. Braun Melsungen AG
- Baxter International Inc.
- Fresenius Kabi AG
- ICU Medical Inc.
- JW Lifescience Corp.
- Merit Medical Systems Inc.
- PolyCine GmbH
- Sippex - A MEDIPPEX Co.
- Smiths Medical Group Ltd.
The intravenous fluid bags market is fragmented and the vendors are deploying growth strategies such as focusing on product innovation and increasing the existing product capabilities to compete in the market.
More insights on the market share of various regions with latest vendor news & product offerings. Request for Details
Market Dynamics
- Rising Prevalence of Chronic Diseases to Drive the Market Growth:
- The Centers for Disease Control and Prevention (CDC) reported that around 795,000 people in the US suffer from a stroke every year. About 87% of these people get ischemic strokes, which leads to blockage of the arteries leading to the brain. In such cases, surgeries such as embolectomy, angioplasty, and surgical arteriovenous malformation repair are performed to remove the blood clot. Chronic conditions such as diabetes are increasing the prevalence of diabetic retinopathy, which can damage the blood vessels of the retina, leading to blindness. Moreover, the rising prevalence of diabetes in the US will increase the number of diabetic retinopathy cases, which will increase the demand for intravenous fluid bags in the market. Similarly, the number of surgeries for breast and ovarian cancer has increased in Australia, driving the demand for intravenous fluid bags in the country. Essentially, the increasing prevalence of chronic diseases is driving the global intravenous fluid bags market growth during the forecast period.
- Technological Innovations will be a Key Trend of the Market in the Near Future:
- Vendors that offer intravenous fluid bags are focused on improving the features of their products. They have developed specialized intravenous blood fluid bags that can withstand low temperatures and offer a high level of safety. For instance, the Reusable Pressure Infusion Bag by Pacific Hospital Supply is a reusable latex-free polyurethane (PU) bag that is used for the infusion of blood, blood plasma, and other liquids. Similarly, in April 2019, Amcor Plc. launched a recyclable, high-barrier flexible packaging, AmLite Ultra Recyclable, for packaging pharmaceutical products. Companies also use this high-barrier flexible packaging product to pack up a range of food, home care, and personal care products. Moreover, the vendors have also developed customized intravenous fluid bags to provide personalized therapeutic solutions. For instance, Technoflex provides 2-CHAMBER BAGS made of DEHP-free or PP material. They are used to provide customized solutions to various applications such as parenteral nutrition and drug reconstruction. Such innovations in intravenous fluid bags drive the global intravenous fluid bags market growth.
This Market Report gives insights on the latest drivers, trends, and challenges that will help companies evaluate and develop growth strategies. Learn More
COVID Impact and Recovery Analysis
Many elective surgeries, such as the appendix, kidney, and gallbladder stone surgeries were postponed for two to three months in early 2020 to prevent the spread of COVID-19. More than 500,000 surgical procedures were either postponed or canceled in 2020, which led to a decline in the adoption of intravenous fluid bags. However, in 2021, the initiation of large-scale vaccination drives has lifted the lockdown and travel restrictions, which led to the resumption of supply chain activities. Such factors are expected to drive the market during the forecast period.
Related Reports
Pressure Infusion Bags Market by Type and Geography - Forecast and Analysis 2022-2026: The pressure infusion bags market share is expected to increase by USD 2.63 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.97%. Find More Exclusive Research Insights Here
Medical Specialty Bags Market by Product, End-user, and Geography - Forecast and Analysis 2021-2025: The medical specialty bags market has the potential to grow by USD 5.26 billion during 2021-2025, and the market's growth momentum will accelerate at a CAGR of 5.50%. Find More Exclusive Research Insights Here
Table of Contents
1 Executive Summary
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 01: Parent market
- Exhibit 02: Market characteristics
- 2.2 Value chain analysis
- Exhibit 03: Value chain: Healthcare supplies
3 Market Sizing
- 3.1 Market definition
- Exhibit 04: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 05: Market segments
- 3.4 Market outlook: Forecast for 2020 - 2025
- Exhibit 06: Global - Market size and forecast 2020 - 2025 ($ million)
- Exhibit 07: Global market: Year-over-year growth 2020 - 2025 (%)
4 Five Forces Analysis
- 4.1 Five Forces Analysis
- Exhibit 08: Five forces analysis 2020 & 2025
- 4.2 Bargaining power of buyers
- Exhibit 09: Bargaining power of buyers
- 4.3 Bargaining power of suppliers
- Exhibit 10: Bargaining power of suppliers
- 4.4 Threat of new entrants
- Exhibit 11: Threat of new entrants
- 4.5 Threat of substitutes
- Exhibit 12: Threat of substitutes
- 4.6 Threat of rivalry
- Exhibit 13: Threat of rivalry
- 4.7 Market condition
- Exhibit 14: Market condition - Five forces 2020
5 Market Segmentation by End-user
- 5.2 Comparison by End-user
- 5.3 Hospitals - Market size and forecast 2020-2025
- Exhibit 17: Hospitals - Market size and forecast 2020-2025 ($ million)
- Exhibit 18: Hospitals - Year-over-year growth 2020-2025 (%)
- 5.4 Home healthcare - Market size and forecast 2020-2025
- Exhibit 19: Home healthcare - Market size and forecast 2020-2025 ($ million)
- Exhibit 20: Home healthcare - Year-over-year growth 2020-2025 (%)
- 5.5 Others - Market size and forecast 2020-2025
- Exhibit 21: Others - Market size and forecast 2020-2025 ($ million)
- Exhibit 22: Others - Year-over-year growth 2020-2025 (%)
- 5.6 Market opportunity by End user
- Exhibit 23: Market opportunity by End user
6 Customer landscape
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 25: Market share by geography 2020-2025 (%)
- 7.2 Geographic comparison
- Exhibit 26: Geographic comparison
- 7.3 Asia - Market size and forecast 2020-2025
- Exhibit 27: Asia - Market size and forecast 2020-2025 ($ million)
- Exhibit 28: Asia - Year-over-year growth 2020-2025 (%)
- 7.4 North America - Market size and forecast 2020-2025
- Exhibit 29: North America - Market size and forecast 2020-2025 ($ million)
- Exhibit 30: North America - Year-over-year growth 2020-2025 (%)
- 7.5 Europe - Market size and forecast 2020-2025
- Exhibit 31: Europe - Market size and forecast 2020-2025 ($ million)
- Exhibit 32: Europe - Year-over-year growth 2020-2025 (%)
- 7.6 ROW - Market size and forecast 2020-2025
- Exhibit 33: ROW - Market size and forecast 2020-2025 ($ million)
- Exhibit 34: ROW - Year-over-year growth 2020-2025 (%)
- 7.7 Key leading countries
- Exhibit 35: Key leading countries
- 7.8 Market opportunity by geography
- Exhibit 36: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.2 Market challenges
- Exhibit 37: Impact of drivers and challenges
9 Vendor Landscape
- 9.1 Vendor landscape
- Exhibit 38: Vendor landscape
- 9.3 Landscape disruption
- Exhibit 39: Landscape disruption
- Exhibit 40: Industry risks
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 41: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 42: Market positioning of vendors
- 10.3 Amcor Plc
- Exhibit 43: Amcor Plc - Overview
- Exhibit 44: Amcor Plc - Business segments
- Exhibit 45: Amcor Ltd. - Key news
- Exhibit 46: Amcor Plc - Key offerings
- Exhibit 47: Amcor Plc - Segment focus
- 10.4 B. Braun Melsungen AG
- Exhibit 48: B. Braun Melsungen AG - Overview
- Exhibit 49: B. Braun Melsungen AG - Business segments
- Exhibit 50: B. Braun Melsungen AG - Key news
- Exhibit 51: B. Braun Melsungen AG - Key offerings
- Exhibit 52: B. Braun Melsungen AG - Segment focus
- 10.5 Baxter International Inc.
- 10.6 Fresenius Kabi AG
- Exhibit 58: Fresenius Kabi AG - Overview
- Exhibit 59: Fresenius Kabi AG - Product and service
- Exhibit 60: Fresenius Kabi AG - Key news
- Exhibit 61: Fresenius Kabi AG - Key offerings
- Exhibit 62: Fresenius Kabi AG - Segment focus
- 10.7 ICU Medical Inc.
- Exhibit 63: ICU Medical Inc. - Overview
- Exhibit 64: ICU Medical Inc. - Business segments
- Exhibit 65: ICU Medical Inc. - Key news
- Exhibit 66: ICU Medical Inc. - Key offerings
- 10.8 JW Lifescience Corp.
- Exhibit 67: JW Lifescience Corp. - Overview
- Exhibit 68: JW Lifescience Corp. - Product and service
- Exhibit 69: JW Lifescience Corp. - Key offerings
- 10.9 Merit Medical Systems Inc.
- Exhibit 70: Merit Medical Systems Inc. - Overview
- Exhibit 71: Merit Medical Systems Inc. - Business segments
- Exhibit 72: Merit Medical Systems Inc. - Key offerings
- Exhibit 73: Merit Medical Systems Inc. - Segment focus
- 10.10 PolyCine GmbH
- Exhibit 74: PolyCine GmbH - Overview
- Exhibit 75: PolyCine GmbH - Product and service
- Exhibit 76: PolyCine GmbH - Key offerings
- 10.11 Smiths Group Plc
- Exhibit 77: Smiths Group Plc - Overview
- Exhibit 78: Smiths Group Plc - Product and service
- Exhibit 79: Smiths Group Plc - Key offerings
- 10.12 SSY Group Ltd.
- Exhibit 80: SSY Group Ltd. - Overview
- Exhibit 81: SSY Group Ltd. - Business segments
- Exhibit 82: SSY Group Ltd. - Key news
- Exhibit 83: SSY Group Ltd. - Key offerings
- Exhibit 84: SSY Group Ltd. - Segment focus
11 Appendix
- 11.2 Currency conversion rates for US$
- Exhibit 85: Currency conversion rates for US$
- 11.3 Research methodology
- Exhibit 86: Research Methodology
- Exhibit 87: Validation techniques employed for market sizing
- Exhibit 88: Information sources
- 11.4 List of abbreviations
- Exhibit 89: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article